Drugs in Context is a peer-reviewed english-language open-access journal published by BioExcel Publishing Ltd in United Kingdom, operating under an open-access model since 2005. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Drugs in Context; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
To date, Drugs in Context has published 571 articles. Articles are minted with DOIs through the prefix 10.7573.
Keywords
pharmacotherapy, real-world medicine, disease management, drugs, health economics, health outcomes
At a glance
- Publisher
- BioExcel Publishing Ltd
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Anonymous peer review
- OA since
- 2005
- DOI prefix
10.7573
ISSN
- electronic
- 1740-4398
Frequently asked questions
Is Drugs in Context peer-reviewed?
Yes — Drugs in Context operates a Anonymous peer review review process.
Does Drugs in Context charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Drugs in Context publish?
Drugs in Context publishes research in Therapeutics. Pharmacology.
What languages does Drugs in Context accept?
Drugs in Context accepts manuscripts in English.
What is the ISSN of Drugs in Context?
ISSN:
1740-4398 (electronic).How do I submit a manuscript to Drugs in Context?
Submit through the journal's official portal: visit submission page →